.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Julphar
Healthtrust
Johnson and Johnson
Chubb
McKesson
AstraZeneca
Dow
Merck

Generated: September 20, 2017

DrugPatentWatch Database Preview

Erythromycin - Generic Drug Details

« Back to Dashboard

What are the generic sources for erythromycin and what is the scope of erythromycin patent protection?

Erythromycin
is the generic ingredient in fifty-two branded drugs marketed by Hi Tech Pharma, Taro, Altana, Merz Pharms, Mylan Pharms Inc, Paddock Llc, Dista, Perrigo Co, Arbor Pharms Llc, Akorn, Pharmafair, Parke Davis, Fougera Pharms, Dow Pharm, Wockhardt, Alpharma Us Pharms, Westwood Squibb, Renaissance Pharma, Barr, Lilly, Robins Ah, Mayne Pharma, Warner Chilcott Llc, Perrigo New York, Bausch And Lomb, Pharmaderm, Perrigo Co Tennessee, Ivax Sub Teva Pharms, Teligent Pharma Inc, Solvay, Syosset, Arbor Pharms Inc, Hospira, Johnson And Johnson, Life Labs, G And W Labs Inc, Watson Labs, Ross Labs, Wyeth Ayerst, Mylan, Ani Pharms Inc, Naska, Pharmacia And Upjohn, Alra, Abraxis Pharm, Teva Parenteral, Elkins Sinn, Abbott, Baxter Hlthcare, Bristol, Bristol Myers Squibb, Warner Chilcott, Purepac Pharm, Lederle, and Pfizer, and is included in one hundred and twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are ninety-eight drug master file entries for erythromycin. Thirty-six suppliers are listed for this compound.

Summary for Generic Name: erythromycin

Tradenames:52
Patents:0
Applicants:55
NDAs:122
Drug Master File Entries: see list98
Suppliers / Packagers: see list36
Bulk Api Vendors: see list42
Clinical Trials: see list94
Patent Applications: see list1,287
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:erythromycin at DailyMed

Pharmacology for Ingredient: erythromycin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc
ERYTHROMYCIN STEARATE
erythromycin stearate
TABLET;ORAL061461-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
ILOSONE
erythromycin estolate
CAPSULE;ORAL061897-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Barr
ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
erythromycin ethylsuccinate; sulfisoxazole acetyl
GRANULE;ORAL062759-001May 20, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Dista
ILOTYCIN GLUCEPTATE
erythromycin gluceptate
INJECTABLE;INJECTION050370-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Arbor Pharms Llc
ERYPED
erythromycin ethylsuccinate
GRANULE;ORAL050207-003Mar 30, 1987ABRXYesNo► Subscribe► Subscribe► Subscribe
Ross Labs
PEDIAMYCIN
erythromycin ethylsuccinate
GRANULE;ORAL062305-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Purepac Pharm
ERYTHROMYCIN STEARATE
erythromycin stearate
TABLET;ORAL061743-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Arbor Pharms Llc
ERYTHROMYCIN
erythromycin
TABLET;ORAL061621-001Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe► Subscribe
Pharmafair
ERYTHROMYCIN
erythromycin
SOLUTION;TOPICAL062616-001Jul 25, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
ERYTHROMYCIN STEARATE
erythromycin stearate
TABLET;ORAL061505-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Cipla
Express Scripts
Cantor Fitzgerald
Julphar
AstraZeneca
Novartis
McKesson
US Department of Justice
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot